TILT Biotherapeutics in a $25.6 million Series B funding led by EIC Fund, Lifeline Ventures, Finnish Industry Investment TESI, and Stephen Industries
02 May 2025
02 May 2025
Total investments received (USD): 62.39M
Round value (USD): 25.6M
Company: TILT Biotherapeutics
Industry: BiotechHealth services
Related deals
Step Pharma raised a €38M Series C led by V-Bio Ventures, joined by Pontifax, Bpifrance, Kurma Partners, Hadean Ventures, Sunstone and Inserm Transfert
Investments
03 October 2025
Phagos raised €25 million series A co-led by CapAgro, Hoxton Ventures, CapHorn and Demeter, joined by Acurio, Citizen Capital, EF, Founders Capital.
Investments
01 October 2025
Arthex Biotech in a series B extension led by Bpifrance, now totalling $87 million
Investments
06 September 2025
Highlight Therapeutics raises €22.6M in a round led by Buenavista, joined by Advent Life Sciences, Columbus Venture Partners in Spain
Investments
04 September 2025
Alchemab raised $32m in Series A extension funding from OVI, RA Capital, SV Health Investors, DCVC Bio , Lightstone Ventures, and Eli Lilly.
Investments
03 September 2025
Netherlands
Austria
Germany
Switzerland
Estonia
Iceland
Latvia
Lithuania
Ireland
Italy